Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$2.24+$0.0050 (+0.22%) on the dayAs of the close; data may be delayed.
ABOS price, last 12 months
Key stats
- Previous close
- $2.24
- Open
- $2.25
- Day range
- $2.22 – $2.30
- 52-week range
- $1.30 – $3.60
- Volume
- 235.3K
- Avg volume (20 days)
- 385.5K
- Market cap
- $162.0M
Performance
1W−15.5%
1M−25.1%
3M−5.1%
6M−12.2%
YTD+6.2%
1Y+76.4%
vs S&P 500, 1Y+59.6 pts
Technicals and fundamentals
About Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $162.0M